LOGICBIO THERAPEUTICS INC - COM (LOGC)

CUSIP: 54142F102

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / COM
Total 13F shares
15,989,024
Share change
+247,979
Total reported value
$73,226,241
Price per share
$4.58
Number of holders
52
Value change
+$1,169,723
Number of buys
15
Number of sells
27

Quarterly Holders Quick Answers

What is CUSIP 54142F102?
CUSIP 54142F102 identifies LOGC - LOGICBIO THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LOGICBIO THERAPEUTICS INC - COM (LOGC) as of Q3 2021

As of 30 Sep 2021, LOGICBIO THERAPEUTICS INC - COM (LOGC) was held by 52 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 15,989,024 shares. The largest 10 holders included ORBIMED ADVISORS LLC, FRANKLIN RESOURCES INC, SAMLYN CAPITAL, LLC, VANGUARD GROUP INC, Lion Point Capital, LP, BAKER BROS. ADVISORS LP, Eversept Partners, LP, PLATINUM INVESTMENT MANAGEMENT LTD, FMR LLC, and PURA VIDA INVESTMENTS, LLC. This page lists 52 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.